BBTV

About Us

all episodes

Multiple Sclerosis Breakthrough, Dr. Laurence Steinman

Nature Medicine and BioBusiness.TV present Science Breakthrough
  1. New Blood Test Predicts Efficacy of Multiple Sclerosis Drug Beta Interferon
  2. 1-in-4 MS Patients Could Be IL17 Non-Responders to the $4Bn Revenue Beta Interferon Drug
  3. IL17 to Multiple Sclerosis as KRAS to Colon Cancer?
  4. When Will the 300,000+ Patients on Beta Interferon Benefit From Dr Steinman’s Breakthrough Study?
  5. Impact of IL17 on MS Drugs in the Pipeline, and Potential Applicability in PML

Osteoporosis Breakthrough, Professor Gerard Karsenty

Nature Medicine and BioBusiness.TV present Science Breakthrough
  1. Major Breakthrough in $5bn Osteoporosis Market
  2. Inhibiting Serotonin Synthesis in the Gut, Rationale for Treating Osteoporosis
  3. How Does an Anabolic Treatment Compare to Other Approaches in Development for Osteoporosis?
  4. Study of Rare Genetic Disease Leads to New Target for the Treatment of Most Common Bone Disease
  • Best of the Web

    • Alzheimer's Disease
    • Antibiotic Resistance
    • Cancer Immunotherapy
    • Cell Therapy
    • Hepatitis C
    • LOL
    • Stem Cells
    • - View All -
  • Series

    • The Stem Cell Review
    • Cancer Immunotherapy
  • Shows

    • Biotech in the Money
    • Wall Street On BBTV
    • Science Breakthrough
    • The Jan Buck Show
    • Special Interview
    • Report on Location
  • Corporate Videos

    • 60sec Pitches
    • Investor Presentations
    • Panorama
  • Store

    • Series Sponsorship
    • Corp. Communications
    • DVDs
  • ABOUT BIOBUSINESS.TV
  • BioBusiness.TV is the first independent Internet TV Network for biotechnology professionals. We create and syndicate video-based industry focused shows and series that range from scientific breakthroughs, to equity analyst insights, as well as C-level executive and investor interviews on strategy, management, policy, marketing, science and more. We strive to enhance the quality and accessibility of industry video programming, and to deliver information biotechnology professionals can rely on to make sound and informed decisions.

  • PARTNERING WITH BIOBUSINESS.TV
  • If you’ve got great video programs and a growing audience, let BioBusiness.TV help you take it to the next level through our Partner Program. You can reach out to us through our ‘contact us’ page.

  • DISCLAIMER
  • Viewers should verify all claims and do their own due diligence before investing in any securities mentioned on BioBusiness.TV.

  • COPYRIGHT © 2011 BIO BUSINESS TV, INC. All Rights Reserved